Cambridge, United Kingdom

Willem Ouwehand

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: University of Cambridge, Other. Active years: 2010-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Willem Ouwehand. Retrieved from https://idiyas.com/inventor/willem-ouwehand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0


 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Islington, London, N1 1BZ, GB (2010)
  • London, GB (2012)
  • Cambridge, GB (2010 - 2020)

Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Willem Ouwehand

Introduction

Willem Ouwehand is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of methods related to stem cell programming and antibody production. With a total of 5 patents, Ouwehand's work has the potential to impact various medical applications.

Latest Patents

Ouwehand's latest patents include groundbreaking inventions such as "Transcription factor mediated programming towards megakaryocytes." This invention focuses on the forward programming of pluripotent stem cells (PSCs) into megakaryocyte (MK) progenitor cells using specific transcription factors like GATA1, FLI1, and TAL1. Additionally, he has developed methods for producing MK progenitor cells and differentiating them into mature megakaryocytes. Another notable patent is "Human antibodies against human glycoprotein VI and their use." This patent describes specific binding members directed to human glycoprotein VI (GPVI), particularly human antibodies that exhibit advantageous properties, including the ability to inhibit collagen-induced platelet aggregation.

Career Highlights

Throughout his career, Ouwehand has worked at esteemed institutions, including the University of Cambridge. His research has contributed to advancements in the understanding of megakaryocyte biology and the development of therapeutic antibodies. His innovative approaches have garnered attention in the scientific community.

Collaborations

Ouwehand has collaborated with notable colleagues such as Andre Schuh and Peter Alexander Smethurst. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Willem Ouwehand's contributions to biotechnology through his patents and research have the potential to advance medical science significantly. His innovative work in stem cell programming and antibody development showcases the importance of creativity and collaboration in scientific progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…